1 |
Ang KK, Mason KA, Meyn RE (2002). Epidermal growth factor receptor (EGFR) and its inhibition in radiotherapy; 7th International Meeting on Progress in Radio-OncologyICRO/PGRO; Salzburg, Austria: Medimond, Inc pp 557-67.
|
2 |
Toulany M, Rodemann HP (2010). Membrane receptor signaling and control of DNA repair after exposure toionizing radiation. Nuklearme Dizin, 49, S26-30.
|
3 |
Carracedo A, Pandolfi PP (2008). The PTEN-PI3K pathway: of feedbacks and cross-talks. Oncogene, 27, 5527-41.
DOI
ScienceOn
|
4 |
Chen DJ, Nirodi CS (2007). The epidermal growth factor receptor: a role in repair of radiation-induced DNA damage. Clin Cancer Res, 13, 6555-60.
DOI
ScienceOn
|
5 |
Fryknas M, Dhar S, Oberg F, et al (2007). STAT1 signaling is associated with acquired cross resistance to doxorubicin and radiation in myeloma cell lines. Int J Cancer, 120, 189-95.
DOI
|
6 |
Golding SE, Morgan RN, Asams BR, et al (2009). Pro-survival AKT and ERK signaling from EGFR and mutant EGFRvIII enhances DNA double-strand break repair in human glioma cells. Cancer Biol Ther, 8, 730-8.
DOI
|
7 |
Hiro J, Inoue Y, Toiyama Y, Miki C, Kusunoki M (2008). Mechanism of resistance to chemoradiation in p53 mutant human colon cancer. Int J Oncol, 32, 1305-10.
|
8 |
Khodarev NN, Minn AJ, Efimova EV, et al (2007). Signal transducer and activator of transcription 1 regulates both cytotoxic and prosurvival functions in tumor cells. Cancer Res, 67, 9214-20.
DOI
|
9 |
Kriegs M, Kasten-Pisula U, Rieckmann T, et al (2010). The epidermal growth factor receptor modulates DNA doublestrand break repair by regulating non-homologous endjoining. DNA Repair (Amst), 9, 889-97.
DOI
|
10 |
Liccardi G, Hartley JA, Hochhauser D (2011). EGFR nuclear translocation modulates DNA repair following cisplatin and ionizing radiation treatment. Cancer Res, 71, 1103-14.
DOI
|
11 |
Meister N, Shalaby T, von Bueren AO, et al (2007). Interferon-gamma mediated up-regulation of caspase-8 sensitizes medulloblastoma cells to radio- and chemotherapy. Eur J Cancer, 43, 1833-41.
DOI
|
12 |
Rodemann HP, Dittmann K, Toulany M (2007). Radiationinduced EGFR-signaling and control of DNA-damage repair. Int J Radiat Biol, 83, 781-91.
DOI
ScienceOn
|
13 |
Meyn RE, Munshi A, Haymach JV, Milas L, Ang KK (2009). Signaling as a regulatory mechanism of DNA repair. Radiother Oncol, 92, 316-22.
DOI
ScienceOn
|
14 |
Mukherjee B, Choy H, Nirodi C, Burma S (2010). Targeting nonhomologous end-joining through epidermal growth factor receptor inhibition: rationale and strategies for radiosensitization. Semin Radiat Oncol, 20, 250-7.
DOI
|
15 |
Ono M, Kuwano M (2006). Molecular mechanisms of epidermal growth factor receptor (EGFR) activationand response to gefitinib and other EGFR-targeting drugs. Clin Cancer Res, 12, 7242-51.
DOI
ScienceOn
|
16 |
Sartor CI (2004). Mechanisms of disease: Radiosensitization by epidermal growth factor receptor inhibitors. Nat Clin Pract Oncol, 1, 80-7.
|
17 |
Szumiel I (2006). Epidermal growth factor receptor and DNA double strand break repair: the cell's self-defence. Cell Signal, 18, 1537-48.
DOI
|
18 |
Tanaka T, Munshi A, Brooks C, et al (2008). Gefitinibradiosensitizes non-small cell lung cancer cells by suppressing cellular DNA repair capacity. Clin Cancer Res, 14, 1266-73.
DOI
|
19 |
Toulany M, Dittmann K, Fehrenbacher B, et al (2008). PI3K-Akt signaling regulates basal, but MAP-kinase signaling regulates radiation-induced XRCC1 expression in human tumor cells in vitro. DNA Repair (Amst), 7, 1746-56.
DOI
|
20 |
Toulany M, Kehlbach R, Florczak U, et al (2008). Targeting of AKT1 enhances radiation toxicity of human tumor cells by inhibiting DNA-PKcs-dependent DNA double-strand break repair. Mol Cancer Ther, 7, 1772-81.
DOI
|